AnalystsDaniel BrimsDaniel Brims's Stock Forecasts
AnalystsDaniel Brims
Sectors:
Industries:
Analyst Ranking
Bottom 13%
#4892 out of 5558 analysts
Average Return
-26.6%
Win Rate
0%0 out of 7
Risk vs Reward
Poor
Good
Daniel Brims's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
No Ratings AvailableDaniel Brims doesn't have any winning ratings in our database | |||||
Daniel Brims Analyst Color
Get additional color on Daniel Brims's coverage of popular stocks
Daniel Brims's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rezolute IncRZLT | 2 | Strong Buy | $12.00 | +228.32% | Maintains | a month ago |
Spruce Biosciences IncSPRB | 1 | Strong Buy | $149.00 | +244.03% | Initiates Coverage On | 2 months ago |
Kyntra Bio IncKYNB | 1 | Strong Buy | $41.00 | +1,091.86% | Initiates Coverage On | 2 months ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $89.00 | +204.59% | Initiates Coverage On | 6 months ago |
Aligos Therapeutics IncALGS | 1 | Strong Buy | $45.00 | +2,042.86% | Initiates Coverage On | 6 months ago |
Kura Oncology IncKURA | 1 | Strong Buy | $23.00 | +196.01% | Initiates Coverage On | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.